At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Near-infrared spectroscopy (NIRS) utilizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Utilization of Near-Infrared Spectroscopy Technology to Determine Normative Cerebral Regional Oxygen Saturation in a Preterm Population Born at Altitude
In Brief
A clinical study evaluating Near-infrared spectroscopy (NIRS) utilization for Prematurity; Extreme. Completed, enrolled 21 participants across 1 site.
Detailed Summary
Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "normal" values is different than those obtained at sea level.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrematurity; Extreme
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartOct 2021
Primary CompletionJun 2023
TodayJul 2026
First PostedNov 20, 2020
Enrollment StartOct 1, 2021
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.6 years ago
Interventions
Near-infrared spectroscopy (NIRS) utilizationdevice
The NIRS devise will be applied so that cerebral regional oxygen saturation (cRSO2) can be measured.